ALP | LDH | ALT | AST | C反应蛋白 | ||
2020/8/26 | CT: 右侧胫骨局限性象牙质密度增高,7.3X3.8cm,考虑右侧胫骨近侧干骺端内侧缘骨肉瘤(成骨型) | |||||
胸部平扫未见明确异常 | ||||||
2020/8/28 | MR:左胫骨上端异常信号伴周围软组织肿胀,临近肌肉组织及左膝前交叉韧带水肿 | |||||
2020/9/12 | 118 | 139 | 43 | 21 | 化疗:和乐生+立幸 | |
2020/10/1 | 102 | 150 | 48 | 28 | 化疗:顺铂+立幸 | |
2020/10/19 | MR:左胫骨上端异常信号伴周围软组织肿块同前;邻近肌肉组织及左膝前交叉韧带水肿较前减轻 | |||||
2020/10/21 | 89 | 139 | 29 | 23 | ||
2020/10/23 | 72 | 21 | 27 | 10.01 | 胫骨肿块切除术 | |
免疫组化:P16强+, CDK4+, SATB2少部分+, P53 40%+, CyclinD1 10%+, Ki67 5%+, CD34-, Actin-, CD31- | ||||||
2020/10/26 | 85 | 26 | 29 | 120 | ||
2020/10/29 | 103 | 35 | 26 | 27 | ||
2020/11/17 | 化疗:多柔比星脂质体+奈达铂 | |||||
2020/12/8 | 化疗:多柔比星脂质体+环磷酰胺 | |||||
2020/12/28 | 85 | 164 | 26 | 21 | CT: 右肺上叶前段、右肺下叶背段实性结节 | |
2020/12/30 | 77 | 16 | 19 | |||
2021/1/3 | 96 | 26 | 24 | 171 | ||
2021/2/3 | 化疗:多柔比星脂质体+紫杉醇 | |||||
2021/3/8 | 化疗:多柔比星脂质体+奈达铂 | |||||
2021/4/8 | 化疗:多柔比星脂质体+异环磷酰胺 | |||||
2021/4/29 | 化疗:多柔比星脂质体+多西他赛 | |||||
2021/7/22 | 化疗:多柔比星脂质体+白蛋白紫杉醇+恩度 |
欢迎光临 探论癌症临床管理研究所 (http://www.tanlunforcancer.net/) | X3.4 |